JPS6442418A - Liposome/anthraquinone drug composition and therapy therewith - Google Patents
Liposome/anthraquinone drug composition and therapy therewithInfo
- Publication number
- JPS6442418A JPS6442418A JP19514787A JP19514787A JPS6442418A JP S6442418 A JPS6442418 A JP S6442418A JP 19514787 A JP19514787 A JP 19514787A JP 19514787 A JP19514787 A JP 19514787A JP S6442418 A JPS6442418 A JP S6442418A
- Authority
- JP
- Japan
- Prior art keywords
- liposome
- anthraquinone
- doxorubicin
- composition
- lipid bilayer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: To obtain a medical composition reduced in peroxylipids and free radial injuries by introducing a lipophilic free radical scavenger into a lipid bilayer part of a liposome and including a trihydroxamic chelating agent in the composition. CONSTITUTION: This composition comprises a liposome containing at least 0.1mol%, preferably 0.2-2mol% lipophilic free radical scavenger (e.g. α-tocopherol) introduced into a lipid bilayer part, an anthraquinone medicine having a quinone and a hydroquinone functional part in the adjacent anthraquinone ring (e.g. an anthracycline glycoside-based antibiotic agent such as doxorubicin or daunorubicin) and a trihydroxamic acid chelating agent present as a ferric ion in an excessive molar amount such as ferrioxamine. The size is mainly within the range of 0.05-0.25μm. An aqueous suspension containing at least 2.5mol% doxorubicin or its analog is administered to treat primary or secondary tumor of the liver.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/806,084 US4797285A (en) | 1985-12-06 | 1985-12-06 | Lipsome/anthraquinone drug composition and method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6442418A true JPS6442418A (en) | 1989-02-14 |
Family
ID=25193277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19514787A Pending JPS6442418A (en) | 1985-12-06 | 1987-08-04 | Liposome/anthraquinone drug composition and therapy therewith |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6442418A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583058A (en) * | 1992-09-17 | 1996-12-10 | Mitsubishi Denki Kabushiki Kaisha | Infrared detection element array and method for fabricating the same |
JP2003512313A (en) * | 1999-10-22 | 2003-04-02 | ノブスファルマ ソチエタ ペル アツィオニ | Liposomal preparation of 6,9-bis-[(2-aminoethyl) -amino] benzo [g] isoquinoline-5,10-dionedimaleate |
JP2005513104A (en) * | 2001-12-06 | 2005-05-12 | イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム | Tempamine compositions and methods of use |
-
1987
- 1987-08-04 JP JP19514787A patent/JPS6442418A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583058A (en) * | 1992-09-17 | 1996-12-10 | Mitsubishi Denki Kabushiki Kaisha | Infrared detection element array and method for fabricating the same |
JP2003512313A (en) * | 1999-10-22 | 2003-04-02 | ノブスファルマ ソチエタ ペル アツィオニ | Liposomal preparation of 6,9-bis-[(2-aminoethyl) -amino] benzo [g] isoquinoline-5,10-dionedimaleate |
JP2005513104A (en) * | 2001-12-06 | 2005-05-12 | イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム | Tempamine compositions and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU590378B2 (en) | Anthraquinone drug composition and method | |
MX9700081A (en) | Tacrine pharmaceutical compositions. | |
IL76600A (en) | Method for administering steroidal liposomes, their preparation and pharmaceutical compositions containing them | |
ES8607906A1 (en) | Process for preparing pharmaceutical compositions containing unilamellar liposomes. | |
ES8603264A1 (en) | Enhancement of antimicrobial activity by incorporating mixture of antimicrobial agents into lipid vesicles. | |
GR1001503B (en) | Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses. | |
PT85829A (en) | Therapeutic agents | |
MY109990A (en) | Microfluidised particles of atovaquone and pharmaceutical preparation thereof | |
MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
EP0137543A3 (en) | Pharmaceutical composition for the therapy of peripheral arteriopathies | |
TW261615B (en) | ||
DE58901002D1 (en) | AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES. | |
AU6553790A (en) | Pharmazeutische praparate | |
KR910005858A (en) | Fatty acid therapy | |
IE820539L (en) | Substituted biphenyl compounds | |
AU611113B2 (en) | Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds | |
JPS6442418A (en) | Liposome/anthraquinone drug composition and therapy therewith | |
EP0652755A1 (en) | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine. | |
ES8706027A1 (en) | Topical pharmaceutical compositions for treating vitiligo | |
ES8205190A1 (en) | 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid | |
JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
HU9200015D0 (en) | Podofillotoxine preparation containing triglicerides | |
DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
DE3163920D1 (en) | Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases | |
EG17992A (en) | Preparation of a medicament for arthritis and theumatism |